Lori Mixson

1.1k total citations
26 papers, 700 citations indexed

About

Lori Mixson is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Lori Mixson has authored 26 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Epidemiology. Recurrent topics in Lori Mixson's work include Antibiotic Resistance in Bacteria (3 papers), Diabetes Treatment and Management (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Lori Mixson is often cited by papers focused on Antibiotic Resistance in Bacteria (3 papers), Diabetes Treatment and Management (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Lori Mixson collaborates with scholars based in United States, Belgium and United Kingdom. Lori Mixson's co-authors include Mary Motyl, Chao‐Min Hoe, Kenneth F. Bartizal, Nicholas A. Kartsonis, Carole A. Sable, Clay B. Frederick, Conrad E. Raab, Chan Beals, Dennis Dean and Nathan X. Yu and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Lori Mixson

26 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lori Mixson United States	15	191	139	136	131	118	26	700
Konstantinos Arvanitidis Greece	19	290 1.5×	85 0.6×	151 1.1×	73 0.6×	57 0.5×	44	920
Manasi S. Shah United States	7	402 2.1×	157 1.1×	137 1.0×	172 1.3×	167 1.4×	8	873
Abdul Khader Mohammed United Arab Emirates	21	341 1.8×	197 1.4×	197 1.4×	168 1.3×	61 0.5×	76	1.2k
Ömür Tabak Türkiye	16	165 0.9×	170 1.2×	93 0.7×	133 1.0×	38 0.3×	45	646
Mingrui Xiong China	17	361 1.9×	63 0.5×	128 0.9×	180 1.4×	291 2.5×	28	891
Ji Youn Youn United States	18	389 2.0×	108 0.8×	89 0.7×	36 0.3×	127 1.1×	30	1.1k
Wang Deng China	19	353 1.8×	152 1.1×	105 0.8×	39 0.3×	93 0.8×	47	886
Angela Cozma Romania	15	184 1.0×	136 1.0×	68 0.5×	96 0.7×	49 0.4×	85	747
Shih‐Li Su Taiwan	16	377 2.0×	81 0.6×	107 0.8×	253 1.9×	49 0.4×	37	755

Countries citing papers authored by Lori Mixson

Since Specialization

Citations

This map shows the geographic impact of Lori Mixson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Mixson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Mixson more than expected).

Fields of papers citing papers by Lori Mixson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Mixson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Mixson. The network helps show where Lori Mixson may publish in the future.

Co-authorship network of co-authors of Lori Mixson

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Mixson. A scholar is included among the top collaborators of Lori Mixson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Mixson. Lori Mixson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sloan, Andrew E., Robin Buerki, Christopher Murphy, et al.. (2021). LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma.. Journal of Clinical Oncology. 39(15_suppl). TPS2065–TPS2065. 11 indexed citations

Inman, Brant A., Matthew I. Milowsky, Raj S. Pruthi, et al.. (2021). Abstract P045: LUMINOS-103: A basket trial evaluating the safety and efficacy of PVSRIPO and PVSRIPO in combination with anti-PD-1/L1 checkpoint inhibitors in patients with advanced solid tumors. Molecular Cancer Therapeutics. 20(12_Supplement). P045–P045. 1 indexed citations

Inman, Brant A., Arjun Vasant Balar, Matthew I. Milowsky, et al.. (2021). Abstract CT242: LUMINOS-103: A basket trial evaluating the safety and efficacy of PVSRIPO in patients with advanced solid tumors. Cancer Research. 81(13_Supplement). CT242–CT242. 2 indexed citations

Shankar, Sudha S., R. Ravi Shankar, Lori Mixson, et al.. (2018). Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes. Diabetes. 67(6). 1105–1112. 45 indexed citations

Shankar, Sudha S., Lori Mixson, Manu V. Chakravarthy, et al.. (2017). Metabolic improvements following Roux-en-Y surgery assessed by solid meal test in subjects with short duration type 2 diabetes. BMC Obesity. 4(1). 10–10. 15 indexed citations

Gheysens, Olivier, Andrey Postnov, Christophe M. Deroose, et al.. (2015). Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using ¹⁸F-FDG PET/CT. Journal of Nuclear Medicine. 56(10). 1520–1526. 14 indexed citations

Musser, Bret J., James A. Bolognese, Yue Shentu, et al.. (2014). Early Clinical Development Planning via Biomarkers, Clinical Endpoints, and Simulation: A Case Study to Optimize for Phase 3 Dose Selection. Therapeutic Innovation & Regulatory Science. 49(3). 405–414. 1 indexed citations

Schoeller, Dale A., Achilles Alon, Lori Mixson, et al.. (2012). Segmental Bioimpedance for Measuring Amlodipine-Induced Pedal Edema: A Placebo-Controlled Study. Clinical Therapeutics. 34(3). 580–592. 10 indexed citations

Kauh, Eunkyung, Lori Mixson, Marie‐Pierre Malice, et al.. (2011). Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals. European Journal of Endocrinology. 166(3). 459–467. 46 indexed citations

10.

Kauh, Eunkyung, Lori Mixson, Sudha S. Shankar, et al.. (2011). Short‐term metabolic effects of prednisone administration in healthy subjects. Diabetes Obesity and Metabolism. 13(11). 1001–1007. 17 indexed citations

11.

Chaves, Alysia, et al.. (2006). Cardiovascular monkey telemetry: Sensitivity to detect QT interval prolongation. Journal of Pharmacological and Toxicological Methods. 54(2). 150–158. 41 indexed citations

12.

Kartsonis, Nicholas A., Lori Mixson, Chao‐Min Hoe, et al.. (2005). Caspofungin Susceptibility Testing of Isolates from Patients with Esophageal Candidiasis or Invasive Candidiasis: Relationship of MIC to Treatment Outcome. Antimicrobial Agents and Chemotherapy. 49(9). 3616–3623. 110 indexed citations

13.

Keenan, Kevin P., Chao‐Min Hoe, Lori Mixson, et al.. (2005). Diabesity: A Polygenic Model of Dietary-Induced Obesity from Ad Libitum Overfeeding of Sprague–Dawley Rats and Its Modulation by Moderate and Marked Dietary Restriction. Toxicologic Pathology. 33(6). 650–674. 24 indexed citations

14.

Schaefer, William H., Lori Mixson, Dennis Dean, et al.. (2003). Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats. Toxicology and Applied Pharmacology. 194(1). 10–23. 105 indexed citations

15.

Motyl, Mary, Lori Mixson, Ian R. Friedland, & Gail L. Woods. (2003). Ertapenem: A parenteral, long-acting carbapenem. Clinical Microbiology Newsletter. 25(12). 89–95. 1 indexed citations

16.

Morton, Daniel, Michael R. Elwell, William R. Fairweather, et al.. (2002). The Society of Toxicologic Pathology's Recommendations on Statistical Analysis of Rodent Carcinogenicity Studies. Toxicologic Pathology. 30(3). 415–418. 6 indexed citations

17.

Friedland, Ian R., Lori Mixson, Anup Majumdar, Mary Motyl, & Gail L. Woods. (2002). In vitroActivity of Ertapenem against Common Clinical Isolates in Relation to Human Pharmacokinetics. Journal of Chemotherapy. 14(5). 483–491. 19 indexed citations

18.

Friedland, Ian R., Robin Isaacs, Lori Mixson, Mary Motyl, & Gail L. Woods. (2002). Use of surrogate antimicrobial agents to predict susceptibility to ertapenem. Diagnostic Microbiology and Infectious Disease. 43(1). 61–64. 16 indexed citations

19.

Anderson, Jeffrey L., Gretchen King, Tami L. Bair, et al.. (1999). Association of lipoprotein lipase gene polymorphisms with coronary artery disease. Journal of the American College of Cardiology. 33(4). 1013–1020. 50 indexed citations

20.

Austin, Christopher P., et al.. (1999). Mapping of hKCa3 to chromosome 1q21 and investigation of linkage of CAG repeat polymorphism to schizophrenia. Molecular Psychiatry. 4(3). 261–266. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact